Bisognano J D, Weinberger H D, Bohlmeyer T J, Pende A, Raynolds M V, Sastravaha A, Roden R, Asano K, Blaxall B C, Wu S C, Communal C, Singh K, Colucci W, Bristow M R, Port D J
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado, 80262, USA.
J Mol Cell Cardiol. 2000 May;32(5):817-30. doi: 10.1006/jmcc.2000.1123.
The beta(1)-adrenergic receptor (AR) is the dominant subtype in non-failing and failing myocardium. beta(1)-AR signaling, by the endogenous neurotransmitter norepinephrine, is central to the regulation of myocardial contractility. In heart failure, the beta(1)-AR undergoes subtype-selective downregulation which may protect against the increased cardiac adrenergic drive associated with this pathophysiological state. To examine the hypothesis that chronically increased beta(1)-AR mediated signaling has adverse myocardial effects, transgenic mice overexpressing the human beta(1)-AR in a cardiac-selective context were produced, utilizing an alpha-myosin heavy chain (MHC) promoter. In these mice, beta(1)-AR protein abundance was approximately 24-46-fold (1-2 pmol/mg protein) that of wild-type mice. Histopathological examination of young (4 months old) and old (approximately 9 months old) transgenic mouse hearts consistently demonstrated large areas of interstitial replacement fibrosis, marked myocyte hypertrophy and myofibrilar disarray. In addition, increased expression of the pre-apoptotic marker, Bax, was observed coincident with regions of fibrosis accompanied by an increased apoptotic index, as measured by TUNEL assay. Older non-transgenic mice exhibited a slight tendency towards a decreased fractional shortening, whereas older beta(1)-AR transgenic mice had a marked reduction in fractional shortening (%FS approximately 30) as determined by echocardiography. Additionally, older beta(1)-AR transgenic mice had an increased left ventricular chamber size. In summary, cardiac-directed overexpression of the human beta(1)-AR in transgenic mice leads to a significant histopathological phenotype with no apparent functional consequence in younger mice and a variable degree of cardiac dysfunction in older animals. This model system may ultimately prove useful for investigating the biological basis of adrenergically-mediated myocardial damage in humans.
β1 - 肾上腺素能受体(AR)是正常和衰竭心肌中的主要亚型。内源性神经递质去甲肾上腺素介导的β1 - AR信号传导是心肌收缩力调节的核心。在心力衰竭中,β1 - AR会发生亚型选择性下调,这可能有助于抵御与这种病理生理状态相关的心脏肾上腺素能驱动增加。为了检验长期增加的β1 - AR介导的信号传导具有不良心肌效应这一假说,利用α - 肌球蛋白重链(MHC)启动子,制备了在心脏中选择性过表达人β1 - AR的转基因小鼠。在这些小鼠中,β1 - AR蛋白丰度约为野生型小鼠的24 - 46倍(1 - 2 pmol/mg蛋白)。对年轻(4个月大)和年老(约9个月大)转基因小鼠心脏的组织病理学检查一致显示出大面积的间质替代性纤维化、明显的心肌细胞肥大和肌原纤维排列紊乱。此外,在纤维化区域观察到凋亡前标记物Bax的表达增加,同时通过TUNEL检测测定的凋亡指数也增加。年老的非转基因小鼠表现出轻微的缩短分数降低趋势,而通过超声心动图测定,年老的β1 - AR转基因小鼠的缩短分数显著降低(%FS约为30)。此外,年老的β1 - AR转基因小鼠的左心室腔大小增加。总之,在转基因小鼠中,心脏定向过表达人β1 - AR会导致显著的组织病理学表型,在年轻小鼠中无明显功能后果,而在年老动物中则有不同程度的心脏功能障碍。该模型系统最终可能被证明对研究人类肾上腺素介导的心肌损伤的生物学基础有用。